Open access
Aug 2026
Clinical Impact of the C-Reactive Protein-Albumin- Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer
Background/Aim: The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel prognostic biomarker that simultaneously evaluates three statuses: nutritional, immunological, and inflammatory. In this study, we aimed to clarify the prognostic significance of the CALLY index compared with that of the cachexia index (...
Teruhisa Sakamoto, Kei Urakami, Kentaro Uehira et al.
· In Vivo · 1 citation